Neuro-oncology

Coordinated by Pr.Marc Sanson

Brain cancers are the 1st cause of cancer death before the age of 35. Because of their rarity, their great heterogeneity and their frequent resistance to conventional treatments, they remain poorly known.

The main objectives of this programme are to :

Better understand functional genomics and the role of the tumor microenvironment
Improving diagnosis through innovative and/or non-invasive approaches
To develop personalized therapies and improve the quality of life of patients.

Synthesis for the general public

SonoCloud First Project

The SonoCloud First project, led by Prof. Alexandre Carpentier, head of the neurosurgery department at Pitié-Salpêtrière and coordinator of the […]

Chordoid glioma: a subtype of brain tumour still poorly understood

Chordoid glioma: a subtype of brain tumour still poorly understood Chordoid gliomas are rare brain tumours, resulting from the excessive […]

A glioma to kill

“A glioma to kill “ Short film by Nathalie Magne, post-PhD of the Sanson-Huillard’s team who, on the occasion of […]

Functional consequences of HDI1 and CIC mutations on the cells of origin of oligodendrogliomas

Functional consequences of HDI1 and CIC mutations on the cells of origin of oligodendrogliomas Oligodendrogliomas are primary tumours of the […]

Brain Tumours: Developing Individualized Therapies

CLIP2 Galilée website

Launch of the new CLIP² Galilé website The CLIP² Galilée (INCa Labeled Early Stage Centre), first labeled by the National […]

Genetics and mechanisms involved in resistance to brain tumor treatments

Genetics and mechanisms involved in resistance to brain tumor treatments In an article to be published in the prestigious journal […]

📢 Artificial Intelligence and Oncology seminars

SCAI (Sorbonne Center for Artificial Intelligence), IUC (Institut Universitaire de Cancérologie from AP-HP.Sorbonne Université hospital group) and SiRIC Curamus launch […]